A Calgary doctor predicts generic versions of Ozempic and Wegovy could reduce costs by up to a third. Learn about the patent expiry and five companies seeking approval to manufacture cheaper alternatives in Canada.
Health Canada reviews nine generic semaglutide submissions. Cheaper versions of Ozempic and Wegovy could soon improve access for diabetes and weight loss patients in British Columbia.
Semaglutide, sold as Ozempic, is now off-patent in Canada. This move could slash costs by up to 75%, dramatically increasing access to the popular diabetes and weight-loss drug for Canadians.
Contrary to popular belief, men with larger penises face significant physical and emotional challenges in the bedroom, from causing pain to performance anxiety. Experts explain the reality and how couples can navigate it.
Explore the concept of 'food noise'—the constant mental chatter about eating—and its connection to popular GLP-1 medications like Ozempic. Learn why Canadians are hearing more about this phenomenon.
Generic versions of weight-loss drug Ozempic could slash costs from $400 to under $100 per month in Quebec following a key patent expiration, potentially increasing access for hundreds of thousands.
Professor Svetlana Mojsov, whose research led to revolutionary drugs like Ozempic, has been awarded the 2026 King Faisal Prize in Medicine. Her work is tackling a global obesity crisis.
A Canadian pharmacy platform plans to supply US patients with Ozempic sourced from India starting in 2026, creating a new cross-border pharmaceutical channel. Learn the details and implications.
Pharmaceutical giant Novo Nordisk is considering a strategic rebrand of a lower-price version of Ozempic to compete directly with upcoming generic alternatives. Learn about the potential market shift.
Dr. Sue Pedersen advises patients to consult their doctors individually about using generic or brand-name Ozempic. A pivotal moment for diabetes and weight-loss treatment access in Canada.
Canadian companies can begin producing generic versions of Ozempic starting next week, but experts warn patients should not expect immediate access due to manufacturing and distribution timelines.
Explore how GLP-1 drugs like Ozempic are transforming workplace dynamics, from employer-sponsored benefits to shifting social etiquette. Discover the data behind this growing trend.
A cheeky Christmas display on Victoria Drive in East Vancouver offers a humorous critique of modern trends like AI and Ozempic. See the festive social commentary.
U.S. telehealth giant Hims & Hers acquires Canadian platform Livewell, positioning itself to launch generic semaglutide (Ozempic) in Canada as Novo Nordisk's patent lapses. The move targets a market where two-thirds of adults face weight-related health ch
The World Health Organization has officially endorsed GLP-1 receptor agonist treatments, including drugs like Ozempic, as a key tool to tackle the global obesity epidemic. Learn what this means for public health.
Experts warn injectable weight-loss drugs such as Ozempic are reducing consumer appetites, posing a significant challenge to the fast-food sector's traditional business model in Canada.
New research reveals how diabetes medications Ozempic and Wegovy are transforming Canadian shopping patterns and food consumption. Discover the surprising impacts.
Two million Canadians using GLP-1 drugs like Ozempic are dramatically changing food consumption patterns, removing $3.3 billion annually from Canada's food economy. Learn how this trend affects groceries, restaurants and agriculture.
Discover why some patients experience hair loss while taking GLP-1 medications like Ozempic. Learn about the science behind this side effect and expert recommendations.
Discover the truth about 'Ozempic penis' - the viral claim about GLP-1 medications. Urologists explain why it's an optical illusion and reveal real sexual side effects.
Celebrity chef Gordon Ramsay refuses to create menus for diners on weight-loss drugs like Ozempic, sparking debate. Discover his controversial stance and its potential impact.
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.